← FDA Drug Approvals (Drugs@FDA)

ANDA218374

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HETERO LABS UNIT III · Approved 2025-03-07

Drug application

FDA Application #

ANDA218374

Application type

Abbreviated New Drug Application (Generic)

Brand name

—

Generic name

—

Active ingredients

—

Dosage form

—

Route

—

Marketing status

—

Sponsor

HETERO LABS UNIT III

First approval

2025-03-07

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown